| Product NDC: | 27437-143 |
| Proprietary Name: | AllerNaze |
| Non Proprietary Name: | Triamcinolone Acetonide |
| Active Ingredient(s): | .5 mg/mL & nbsp; Triamcinolone Acetonide |
| Administration Route(s): | NASAL |
| Dosage Form(s): | SPRAY, METERED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 27437-143 |
| Labeler Name: | Lupin Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020120 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110201 |
| Package NDC: | 27437-143-01 |
| Package Description: | 15 mL in 1 BOTTLE, SPRAY (27437-143-01) |
| NDC Code | 27437-143-01 |
| Proprietary Name | AllerNaze |
| Package Description | 15 mL in 1 BOTTLE, SPRAY (27437-143-01) |
| Product NDC | 27437-143 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Triamcinolone Acetonide |
| Dosage Form Name | SPRAY, METERED |
| Route Name | NASAL |
| Start Marketing Date | 20110201 |
| Marketing Category Name | NDA |
| Labeler Name | Lupin Pharmaceuticals |
| Substance Name | TRIAMCINOLONE ACETONIDE |
| Strength Number | .5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |